Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018, Article ID 8503109, 10 pages
https://doi.org/10.1155/2018/8503109
Research Article

Ameliorative Effect of Dangguibuxue Decoction against Cyclophosphamide-Induced Heart Injury in Mice

1Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Nantong, China
2Department of Traditional Chinese Medicine, Affiliated Hospital of Nantong University, Nantong, China
3Department of Obstetrics and Gynecology, Affiliated Hospital of Nantong University, Nantong, China

Correspondence should be addressed to Qing Ye; moc.anis@100gniqeytnsj

Received 27 August 2018; Accepted 25 October 2018; Published 1 November 2018

Academic Editor: Kota V. Ramana

Copyright © 2018 Kun Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Wei, M.-G. You, J.-J. Ling et al., “Regulation of antioxidant system, lipids and fatty acid beta-oxidation contributes to the cardioprotective effect of sodium tanshinone IIA sulphonate in isoproterenol-induced myocardial infarction in rats,” Atherosclerosis, vol. 230, no. 1, pp. 148–156, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. E. S. Henderson and R. J. Samaha, “Evidence that drugs in multiple combinations have materially advanced the treatment of human malignancies,” Cancer Research, vol. 29, no. 12, pp. 2272–2280, 1969. View at Google Scholar · View at Scopus
  3. J.-P. Lévesque, J. Hendy, Y. Takamatsu, P. J. Simmons, and L. J. Bendall, “Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by gcsf or cyclophosphamide,” The Journal of Clinical Investigation, vol. 111, no. 2, pp. 187–196, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Song, C. Zhang, C. Wang et al., “Ferulic Acid against Cyclophosphamide-Induced Heart Toxicity in Mice by Inhibiting NF- B Pathway,” Evidence-Based Complementary and Alternative Medicine, vol. 2016, Article ID 1261270, 8 pages, 2016. View at Google Scholar · View at Scopus
  5. T. Chen, Q. Guo, H. Wang et al., “Effects of esculetin on lipopolysaccharide (LPS)-induced acute lung injury via regulation of RhoA/Rho Kinase/NF-κB pathways in vivo and in vitro,” Free Radical Research, vol. 49, no. 12, pp. 1459–1468, 2015. View at Publisher · View at Google Scholar
  6. L. Zhu, T. Chen, X. Chang et al., “Salidroside ameliorates arthritis-induced brain cognition deficits by regulating Rho/ROCK/NF-κB pathway,” Neuropharmacology, vol. 103, pp. 134–142, 2016. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Zhang, J. Liu, X. You et al., “P2X7 as a new target for chrysophanol to treat lipopolysaccharide-induced depression in mice,” Neuroscience Letters, vol. 613, pp. 60–65, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. X. Chang, H. He, L. Zhu et al., “Protective effect of apigenin on Freund’s complete adjuvant-induced arthritis in rats via inhibiting P2X7/NF-κB pathway,” Chemico-Biological Interactions, vol. 236, pp. 41–46, 2015. View at Publisher · View at Google Scholar
  9. L. Zhu, T. Wei, X. Chang et al., “Effects of salidroside on myocardial injury in vivo in vitro via regulation of Nox/NF-κB/AP1 pathway,” Inflammation, vol. 38, no. 4, pp. 1589–1598, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Chen, L. Xiao, L. Zhu, S. Ma, T. Yan, and H. Ji, “Anti-asthmatic effects of ginsenoside Rb1 in a mouse model of allergic asthma through relegating Th1/Th2,” Inflammation, vol. 38, no. 5, pp. 1814–1822, 2015. View at Publisher · View at Google Scholar
  11. X. Chang, F. Luo, W. Jiang et al., “Protective activity of salidroside against ethanol-induced gastric ulcer via the MAPK/NF-κB pathway in vivo and in vitro,” International Immunopharmacology, vol. 28, no. 1, pp. 604–615, 2015. View at Publisher · View at Google Scholar
  12. X. T. Li, B. Wang, J. L. Li et al., “Effects of dangguibuxue Tang, a Chinese herbal medicine, on growth performance and immune responses in broiler chicks,” Biological Research, vol. 46, no. 2, pp. 183–188, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. G. Jin, “Effects of huangqi in danggui buxue decoction on hematopoietic functions in mice,” Chinese Journal of Basic Medicine in Traditional Chinese Medicine, vol. 3, article 027, 2009. View at Google Scholar
  14. M. Ryu, E. H. Kim, M. Chun et al., “Astragali Radix elicits anti-inflammation via activation of MKP-1, concomitant with attenuation of p38 and Erk,” Journal of Ethnopharmacology, vol. 115, no. 2, pp. 184–193, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Zhou, G. Tang, L. J. Medeiros et al., “Therapy-related myeloid neoplasms following fludarabine, cyclophosphamide, and rituximab (FCR) treatment in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma,” Modern Pathology, vol. 25, no. 2, pp. 237–245, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Viaud, F. Saccheri, G. Mignot et al., “The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide,” Science, vol. 342, no. 6161, pp. 971–976, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Mayaux, D. Roosweil, M. Uzunov, A. Le, C.-E. Luyt, and J. P. Vernant, “Cardiac toxicity of high dose cyclophosphamide post T cell replete HLA haploidentical hematopoietic stem cell transplantation,” Blood, vol. 122, article 5457, 2013. View at Google Scholar
  18. S. Kumar, “Evaluation of antioxidant potential of hesperidine on cyclophosphamide induced cellular myocardial oxidative damage in rats,” CT International Journal of Pharmaceutical & Integrated Life Sciences, vol. 1, 2015. View at Google Scholar
  19. T. Chen, J. Gao, P. Xiang et al., “Protective effect of platycodin D on liver injury in alloxan-induced diabetic mice via regulation of Treg/Th17 balance,” International Immunopharmacology, vol. 26, no. 2, pp. 338–348, 2015. View at Publisher · View at Google Scholar
  20. B. Alvarez, P. Martínez, M. Yuste et al., “Phenotypic and functional heterogeneity of CD169+ and CD163+ macrophages from porcine lymph nodes and spleen,” Developmental & Comparative Immunology, vol. 44, no. 1, pp. 44–49, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Kooijman, I. Meurs, L. van Beek et al., “Splenic autonomic denervation increases inflammatory status but does not aggravate atherosclerotic lesion development,” American Journal of Physiology-Heart and Circulatory Physiology, vol. 309, no. 4, pp. H646–H654, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Kalbitz, M. Huber-Lang, F. Gebhard, and P. Ward, “SEP-10: complement alters cardiac function during sepsis,” Shock, vol. 44, pp. 16-17, 2015. View at Google Scholar
  23. T. Zhang, T. Yan, J. Du, S. Wang, and H. Yang, “Apigenin attenuates heart injury in lipopolysaccharide-induced endotoxemic model by suppressing sphingosine kinase 1/sphingosine 1-phosphate signaling pathway,” Chemico-Biological Interactions, vol. 233, pp. 46–55, 2015. View at Publisher · View at Google Scholar
  24. H. He, X. Chang, J. Gao, L. Zhu, M. Miao, and T. Yan, “Salidroside mitigates sepsis-induced myocarditis in rats by regulating IGF-1/PI3K/Akt/GSK-3β signaling,” Inflammation, vol. 38, no. 6, pp. 2178–2184, 2015. View at Publisher · View at Google Scholar
  25. X.-Y. Deng, J.-J. Chen, H.-Y. Li, Z.-Q. Ma, S.-P. Ma, and Q. Fu, “Cardioprotective effects of timosaponin B II from Anemarrhenae asphodeloides Bge on isoproterenol-induced myocardial infarction in rats,” Chemico-Biological Interactions, vol. 240, article 7431, pp. 22–28, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Cetik, A. Ayhanci, and V. Sahinturk, “Protective effect of carvacrol against oxidative stress and heart injury in cyclophosphamide-induced cardiotoxicity in rat,” Brazilian Archives of Biology and Technology, vol. 58, no. 4, pp. 569–576, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Chen, Y. Mou, J. Tan et al., “The protective effect of CDDO-Me on lipopolysaccharide-induced acute lung injury in mice,” International Immunopharmacology, vol. 25, no. 1, pp. 55–64, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Jiang, F. Luo, Q. Lu et al., “The protective effect of Trillin LPS-induced acute lung injury by the regulations of inflammation and oxidative state,” Chemico-Biological Interactions, vol. 243, pp. 127–134, 2015. View at Publisher · View at Google Scholar
  29. Q. Jiang, M. Yi, Q. Guo et al., “Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway,” International Immunopharmacology, vol. 29, no. 2, pp. 370–376, 2015. View at Publisher · View at Google Scholar
  30. W. Jing, M. Chunhua, and W. Shumin, “Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-kappaB pathway in vivo and in vitro,” Toxicology and Applied Pharmacology, vol. 285, no. 2, pp. 128–135, 2015. View at Publisher · View at Google Scholar
  31. T. Chen, Z. Ma, L. Zhu et al., “Suppressing receptor-interacting protein 140: a new sight for salidroside to treat cerebral ischemia,” Molecular Neurobiology, vol. 53, no. 9, pp. 6240–6250, 2016. View at Publisher · View at Google Scholar
  32. L. Zhu, T. Wei, J. Gao et al., “The cardioprotective effect of salidroside against myocardial ischemia reperfusion injury in rats by inhibiting apoptosis and inflammation,” Apoptosis, vol. 20, no. 11, pp. 1433–1443, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Chen, R. Wang, W. Jiang et al., “Protective effect of astragaloside IV against paraquat-induced lung injury in mice by suppressing Rho signaling,” Inflammation, vol. 39, pp. 483–492, 2016. View at Publisher · View at Google Scholar
  34. B. Wei, W.-W. Li, J. Ji, Q.-H. Hu, and H. Ji, “The cardioprotective effect of sodium tanshinone IIA sulfonate and the optimizing of therapeutic time window in myocardial ischemia/reperfusion injury in rats,” Atherosclerosis, vol. 235, no. 2, pp. 318–327, 2014. View at Publisher · View at Google Scholar · View at Scopus